Board summary
Key figures
48,212
Registered population
59.1% aged 18–64
18.5%
Aged 65+
ICB 18.8% · England 17.9%
14.5%
Ethnic minority (non-White)
6.7% Asian · England 9.6%
0.0%
In IMD quintile 1
ICB 0.8% · England 21.0%
0
Core20 residents (est.)
Resident basis; registered basis 0 · see page 3
6,092
Hypertension register
+0.25% in 3 yrs · England +5.60%
318
SMI register
28.1% of Elmbridge's
548
COPD register
Reviews -12.83% in 3 yrs
Forecast to 2030
6,515
Hypertension patients, 2041
+423 on today
60.9%
QRISK ≥20% on statins, 2041
+2.19pp over 3 yrs
5.5%
Cancer prevalence, 2041
England 4.5%
Three things the board should see
Asthma annual reviews trail after sharp three-year drop.
Coverage fell 23.4% over 2023 to 2025 (England +4.4%) to 49.9% (England 65.7%), leaving about 1,200 of 2,493 register patients unreviewed.
Learning disability and dementia prevalence fell since 2023.
Learning disability (98 patients, 0.2%) fell 4.7% (England +5.4%) and dementia (356 patients) fell 7.7% (England +6.0%), which register audits could test for coding.
Hypertension blood pressure control under 80 outpaced England.
Control under 80 rose +10.9% (England +3.2%) to 66.2%, while treatment to target rose +8.8% (England +3.6%) to 69.3%.
Population, age and ethnicity
Higher child and older population shares accompany projected 5.3% list growth to 2030
WHAM PCN has 48,212 registered patients across three practices. Children aged 0–17 comprise 22.4% (10,796 patients), above Elmbridge (21.7%), the ICB (20.4%) and England (19.6%). Patients aged 65+ make up 18.5% (8,926 patients), exceeding Elmbridge (17.9%) and England (17.9%), while trailing the ICB (18.8%). Primary list size is projected to grow 5.3% to 2030 (Elmbridge 3.6%, ICB 4.9%, England 2.3%), with unverified projection methodology. Census usual residents are 85.5% White (Elmbridge 86.1%, ICB 85.3%, England 81.1%) and 14.5% ethnic minorities; Census resident ethnicity is not registered-patient data.
Age profile
65+: ICB 18.8%, England 17.9%
Ethnicity
Older people · falls rows are Elmbridge local-authority (LA) data, not PCN
| Measure | Local | South East | England | Period |
|---|---|---|---|---|
| Falls admissions, 65+, per 100,000 (Elmbridge LA) | 2,003 | 2,018 | 1,958 | 2024/25 |
| Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN) | 84.3% | 82.2% | 81.9% | 2024/25 |
| Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN) | 58.6% | 57.8% | 57.4% | 2024/25 |
| Falls admissions, 65 to 79, per 100,000 (Elmbridge LA) | 895 | 981 | 955 | 2024/25 |
| Falls deaths, all ages, per 100,000 (Elmbridge LA) | 10.4 | 14.0 | 14.8 | 2022‑24 |
Deprivation and Core20
Average IMD decile is 8.6 with 0.0% of patients in Core20
WHAM PCN averages IMD decile 8.6, matching Elmbridge (8.6) and above NHS Surrey Heartlands Integrated Care Board (7.9) and England (5.5). Across 48,212 registered patients, 0.0% reside in Core20 areas (England 21.0%, ICB 0.8%, Elmbridge 0.0%). Practice concentration and volume are zero across all member surgeries: Fort House Surgery (decile 8.0), Hersham Surgery (8.1), and Phoenix Family Practice (8.8) each record 0.0% share and 0 patients, with 0 of 41 associated LSOAs in deciles 1–2. Zero area-level Core20 deprivation may obscure individual household vulnerability across member practices.
% of patients in IMD quintile 1, by practice
Dashed line: England 21.0% · right column: Core20 patients, registered basis
PLUS groups and inclusion health
PLUS groups and inclusion health
318
SMI register
0.66% recorded prevalence
98
Learning disability register
0.20% recorded prevalence
14
Care homes, 814 beds
In the PCN catchment
7.4%
Provide unpaid care
Elmbridge, Census 2021
Learning disability prevalence is 0.2% (98 patients), trailing Elmbridge (0.3%), the ICB (0.5%) and England (0.6%). Severe mental illness prevalence is 0.7% (318 patients), matching Elmbridge (0.7%) but below the ICB (0.8%) and England (1.0%). Catchment care homes total 14 sites with 814 beds. Crude recorded prevalence across both conditions sits below national benchmarks, though register differences alone do not confirm under-detection or coding variation.
Severe mental illness: physical health checks
SMI blood pressure checks reached 73.7% (England 83.4%, Elmbridge 81.7%), falling 0.3 pp over three years (England +4.4 pp). BMI recording reached 79.3% and alcohol recording in psychosis reached 74.6%.
Clinical focus: hypertension and lipids
Clinical focus: hypertension and lipids
6,092
Hypertension register
+0.25%
Register growth, 3 yrs
Elmbridge +5.83% · England +5.60%
+6.51pp
BP control, under 80
≤140/90 · +3.52pp aged 80+
+423
More patients by 2030
Forecast 6,515 (12.70%)
Hypertension case-finding and control
Recorded hypertension prevalence is 12.6% (6,092 patients), matching Elmbridge (12.6%) but below the ICB (14.3%) and England (15.2%). Slower three-year register growth of +0.2% trails Elmbridge (+5.8%), the ICB (+5.3%) and England (+5.6%), yielding an unadjusted benchmark gap of +1 to +1,251 patients. Practice prevalence ranges from 11.7% at Phoenix Family Practice to 12.8% at Fort House Surgery and 14.8% at Hersham Surgery. Conversely, clinical control improved: blood pressure control under 80 years reached 66.2% after a +10.9% gain (England +3.2%), and treatment to target rose +8.8% to 69.3% (England +3.6%). Faster blood pressure control gains contrast with subdued register growth across practices.
Lipids and statins
Lipid-lowering therapy for patients with QRISK ≥ 20% is 56.2% (Elmbridge 55.9%, England 63.6%). Statin therapy in diabetes without cardiovascular disease fell 7.2% over three years (England +2.1%) to 65.6% (England 73.2%).
| Measure | Items | Cost / item | ICB | England | Annual spend |
|---|---|---|---|---|---|
| Lipid-modifying, 2026 | 46,168 | £2.50 | £2.24 | £1.86 | £115,420 |
| Cardiovascular (all), 2025 | 74,486 | £6.02 | £4.74 | £3.33 | £448,406 |
For lipid-regulating drugs in 2026, WHAM PCN prescribed 46,168 items at £2.50 each, above Elmbridge (£2.25), the ICB (£2.24) and England (£1.86). This unit cost is £29,548 more than at England's unit cost across those items.
Clinical focus: respiratory, cancer register and children
Clinical focus: respiratory, cancer register and children
Respiratory
−23.36%
Asthma reviews, PCN 3-yr % change
+4.44%
Asthma reviews, England 3-yr % change
+4.12%
Asthma prevalence, PCN 3-yr % change
Asthma annual reviews fell 23.4% over three years (England +4.4%, Elmbridge -4.0%) to 49.9%, leaving 1,249 of 2,493 registered patients unreviewed (England 65.7%, Elmbridge 61.6%). Phoenix Family Practice achieved 44.9%, Fort House Surgery 53.0%, and Hersham Surgery 56.4%. COPD reviews fell 12.8% (England +2.8%) to 72.1% (England 76.4%, Elmbridge 76.7%) across a COPD register of 548 patients (1.1% prevalence).
Cancer register and children's immunisation
The cancer register records 2,240 patients (4.7% prevalence; England 3.8%, Elmbridge 4.6%). In childhood immunisation, 12-month 6-in-1 uptake is 91.8% against the 95.0% target. At age 5, MMR2 reaches 91.6% and the 4-in-1 booster 90.1%. Between MMR doses at age five, Fort House Surgery shows an 8.7 pp difference, and Phoenix Family Practice 4.1 pp, indicating second-dose drop-off.
Dashed line: 95% national coverage target · solid tick: England
Early cancer diagnosis
Early cancer diagnosis
61.4%
Surrey Heartlands ICB, stage 1–2
55.3%
England, 2022
75%
National ambition by 2028
~650
Extra early-stage cases a year to reach the ambition
| Stage 1–2 share by cancer type, 2022 | Surrey Heartlands ICB | England | No usable stage | Staged cancers |
|---|---|---|---|---|
| Prostate | 65.7% | 53.2% | 18% | 1,044 |
| Breast | 88.2% | 85.4% | 27% | 798 |
| Bowel | 48.1% | 47.0% | 18% | 626 |
| Lung | 33.2% | 33.8% | 17% | 497 |
| Skin cancer | 89.8% | 87.8% | 19% | 384 |
Across NHS Surrey Heartlands ICB in 2022, 61.4% of cancers with a known stage (2,955 of 4,810) were diagnosed at stage 1 or 2, exceeding England (55.3%) but 13.6 pp below the 75.0% national ambition by 2028. Only 67.7% had a recorded stage. Closing this ICB gap requires approximately 650 (652.5) additional early-stage diagnoses annually. Staging reaches 88.2% in breast, but 48.1% in bowel and 33.2% in lung. At WHAM PCN, crude cancer prevalence is 4.7% (2,240 patients). Cervical screening is 73.7%, falling 1.8% over three years (England -1.0%), with Phoenix Family Practice at 68.8%.
Cancer waits, diagnostics and community services
Cancer waits, diagnostics and community services
Cancer waits and diagnostics, Jul 2026 (provisional)
In July 2026 (provisional), Ashford and St Peter's Hospitals NHS Foundation Trust achieved 85.5% on the cancer 28-day faster diagnosis standard (target 75.0%, England 79.3%, Kingston and Richmond 80.1%, Epsom and St Helier 89.7%). However, 62-day referral to treatment was 76.4%, below the 85.0% standard (NHS Surrey and Sussex ICB 71.5%, England 71.2%). For diagnostics in July 2026, 23.1% of patients waited 6+ weeks across all tests, 49.6% for colonoscopy, and 56.7% for gastroscopy. These provider-level waiting times reflect secondary care pressures rather than PCN performance.
| Pathways within standard (%) | Ashford and St Peter's | Kingston and Richmond | Epsom and St Helier | Surrey and Sussex ICB | England |
|---|---|---|---|---|---|
| 28-day faster diagnosis (75%) | 85.53 | 80.07 | 89.70 | 79.29 | 79.32 |
| 31-day treatment (96%) | 94.21 | 98.77 | 99.16 | 90.45 | 92.50 |
| 62-day referral to treatment (85%) | 76.38 | 75.32 | 86.82 | 71.51 | 71.16 |
| Diagnostic waits over 6 weeks (%) | Ashford and St Peter's | Kingston and Richmond | Epsom and St Helier | England |
|---|---|---|---|---|
| MRI | 0.09 | 0.19 | 0.31 | 21.40 |
| CT | 9.27 | 0.00 | 1.06 | 9.92 |
| Echocardiography | 0.97 | 4.89 | 25.49 | 28.48 |
| Colonoscopy | 49.61 | 70.17 | 33.01 | 30.83 |
| Gastroscopy | 56.74 | 79.18 | 30.90 | 29.02 |
| All 15 DM01 tests | 23.12 | 31.56 | 6.83 | 23.14 |
| Community services activity | Surrey residents | Surrey and Sussex ICB |
|---|---|---|
| Care contacts | 109,530 | 309,615 |
| Referrals | 28,700 | 66,930 |
| Patients with a contact | 33,510 | 85,660 |
Community services (residents of Surrey), Jun 2026 (provisional). In June 2026 (provisional), Surrey recorded 109,530 community care contacts and 66,060 care activities, while NHS Surrey and Sussex Integrated Care Board recorded 309,615 care contacts. Adults aged 65 and over accounted for 69.6% of Surrey resident contacts (76,215 of 109,530). These provisional local authority and ICB figures reflect wider community services activity rather than PCN-level delivery.
Practice variation and patient experience
Patient phone access varies by 56.2 pp across the network's three practices
All three practices achieved 100.0% in the QOF clinical domain (England 97.1%), with overall achievement between 96.3% at Fort House Surgery and 99.6% at Hersham Surgery. However, vaccination and immunisation achievement spans a 29.4 pp range, from 67.5% at Fort House Surgery to 96.9% at Hersham Surgery, alongside personalised care adjustments up to 13.5% at Phoenix Family Practice.
GP Patient Survey by practice
| Practice | Responses | % in IMD Q1 | Phone easy | Request led to appt | Overall good |
|---|---|---|---|---|---|
| Fort House Surgery | 100 | 0.0 | 80.2% | 69.8% | 93.7% |
| Hersham Surgery | 95 | 0.0 | 49.8% | 83.1% | 81.7% |
| Phoenix | 107 | 0.0 | 24.0% | 70.9% | 72.0% |
| England | — | ~21 | 56.9% | 71.6% | 76.7% |
Where the PCN lags
Sixteen of 25 measures trail England over three years, led by falling review rates
Between 2023 and 2025, 16 of 25 measures trailed England. Three-year relative declines were steepest for asthma annual reviews (down 23.4%, England +4.4%), heart failure reviews (down 7.4%, England +8.7%), and dementia prevalence (down 7.7%, England +6.0%). Learning disability prevalence fell 4.7% (England +5.4%, Elmbridge +21.3%). Conversely, blood pressure control under 80 rose +10.9% (England +3.2%) and hypertension treated to target rose +8.8% (England +3.6%).
3-year change · PCN vs England
Bars show the direction and scale of relative change. Orange: PCN · Grey: England.
Asthma reviews
Heart failure reviews
COPD reviews
Dementia register
Learning disability register
BP control, under 80
Hypertension treated to target
Hypertension BP reading
What the data can't tell us: gaps and local assets
What the data can't tell us: gaps and local assets
| Local assets and voluntary sector | PCN | Elmbridge | Asset | PCN | Elmbridge |
|---|---|---|---|---|---|
| Care homes (catchment) | 14 (814 beds) | n/a | Schools (catchment) | 43 | n/a |
| Children's centres | 3 | 8 | Places of worship | 29 | 59 |
| Libraries | 4 | 6 | Homelessness support (VCS) | 0 | no data |
| Day centres (VCS) | 1 | 2 | Carers support groups (VCS) | 1 | 1 |
| Primary schools (LA maintained) | 5 | 15 | Primary academies | 4 | 11 |
| Special schools | n/a | 1 |
0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.
Options for the PCN
Options for the PCN
Each option in full
Option 1
Structured asthma review recall
Asthma reviews are 49.9% (Elmbridge 61.6%, England 65.7%) after a -23.4% change (England +4.4%), leaving 1,249 of 2,493 patients unreviewed. For discussion, run structured asthma recall using a single template, starting at Phoenix Family Practice (44.9% reviewed) alongside Fort House Surgery (53.0%) and Hersham Surgery (56.4%). Moderate effort to run.
Evidence base: the annual asthma review is the process gap between the register and outcomes.
Policy anchor: Core20PLUS5 chronic respiratory disease priority.
Option 2
Learning disability register validation
Learning disability prevalence is 0.2% (98 of 48,212 patients; Elmbridge 0.3%, ICB 0.5%, England 0.6%) after a -4.7% change (Elmbridge +21.3%, England +5.4%), an unadjusted +58 to +185 gap. Moderate effort to run.
Evidence base: the register is the cohort for the annual health check and LeDeR learning; people with a learning disability die on average 20 years earlier and are a Core20PLUS5 PLUS group.
Policy anchor: annual health checks for 75% of people aged 14+ on the register (Network Contract DES); Oliver McGowan mandatory training.
Option 3
Dementia register and care-home review
Dementia prevalence is 0.7% (356 of 48,212 patients; England 0.8%, Elmbridge 0.9%) after a -7.7% change (Elmbridge +7.8%, England +6.0%), an unadjusted +21 to +75 patient gap. Moderate effort to run.
Evidence base: dementia diagnosis rates lag in deprived and minority ethnic populations and in care homes; the register is the cohort for diagnosis-rate improvement and the annual dementia review, and diagnosis and post-diagnostic support delay care-home entry.
Policy anchor: national dementia diagnosis-rate ambition of 66.7%; 95% of people with complex needs to have an agreed care plan by 2027.
Provenance and audit trail
Provenance and audit trail
Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.
| Recommendation | Indicator(s) | Policy anchor | Data level |
|---|---|---|---|
| Household vulnerability screening (p3) | Core20 cohort (IMD quintile 1) | Core20PLUS5 · 10YHP equity test | PCN |
| SMI physical health check recall (p4) | SMI register with a BP check in the last 12 months | MHIS · From Harm to Hope | PCN |
| Hypertension case finding review (p5) | Hypertension: QOF prevalence | Core20PLUS5 CVD · CVDPREVENT 2029 | PCN |
| Pre-school immunisation call and recall (p6) | MMR dose 2 coverage at age 5 | 10YHP sickness to prevention · 95% target | PCN |
| Cervical screening recall outreach (p7) | Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs) | Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026 | PCN |
| Practice telephony and triage review (p9) | GPPS easy to contact the practice by phone | 10YHP, hospital to community | Practice |
| Option 1 · Structured asthma review recall (p12) | Asthma register · Patients with Asthma: review in the last 12 months (denominator incl. PCAs) | Core20PLUS5 respiratory | PCN & Practice |
| Option 2 · Learning disability register validation (p12) | Learning disability register · Learning disability: QOF prevalence · Registered population | 75% annual health checks (Network Contract DES) · Oliver McGowan | PCN |
| Option 3 · Dementia register and care-home review (p12) | Dementia register · Dementia: QOF prevalence · Registered population | 66.7% diagnosis ambition · 95% care plan 2027 | PCN |
Data sources
Data sources
Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.
| Dataset | Level | Period | Used for |
|---|---|---|---|
| Coplug indicator tables: census, deprivation and QOF measures | PCN & Practice | 2023 to 2025, projected to 2030; 2023 to 2024 | Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12 |
| MHCLG, Rough sleeping snapshot in England: autumn 2025 | Local authority | Autumn 2025 | Pages 2, 4 |
| OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) | PCN | 2024/25 | Pages 2, 4 |
| OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002) | Local authority | 2024/25; 2022-24 | Pages 2, 4 |
| ONS, Census 2021 TS039: provision of unpaid care (age-standardised) | Local authority | Census 2021 | Pages 2, 4 |
| QOF registers, prevalence and care processes (Coplug indicator tables) | Practice | 2023 to 2025, projected to 2030 | Pages 4, 5, 6, 7, 8, 10 |
| UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26 | PCN & Practice | Q1 2025/26 | Pages 4, 6 |
| UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026 | ICB | 2025/26 season to 28 Feb 2026 | Pages 4, 6 |
| NHS England, Cancer Waiting Times: July 2026 monthly time series with revisions | ICB & Provider | Jul 2026 (provisional) | Pages 7, 8 |
| NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental data | ICB & Local authority | Jun 2026 (provisional) | Pages 7, 8 |
| NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026 | Provider | Jul 2026 | Pages 7, 8 |
| National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022 | ICB | 2022 | Pages 7, 8 |
| NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted) | Practice | Survey Jan-Apr 2026 | Page 9 |
| NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domain | Practice | 2025/26 | Page 9 |
| NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domain | Practice | 2025/26 | Page 9 |
| Coplug indicator catalogue — definitions, cohorts, policy anchors | Reference | Current | Evidence-base lines, page 13 |
Methods, data-quality notes and limitations
Methods, data-quality notes and limitations
Methods
Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.
Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.
Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.
Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.
